SGH
ALDR

Schonfeld Group Holdings’s Alder Biopharmaceuticals ALDR Stock Holding History

Schonfeld Group Holdings’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,500
Closed -$291K – 258
2015
Q2 		$291K Buy
+5,500
New +$200K 0.27% 46

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Schonfeld Group Holdings's ALDR Position: Q3 2015 in Review

Schonfeld Group Holdings sold out of Alder Biopharmaceuticals (ALDR) in Q3 2015, closing a stake of 5,500 shares — an estimated $291K sold.

Schonfeld Group Holdings first reported a position in ALDR in Q2 2015 and held it in 1 quarter. The position peaked at $291K in Q2 2015. 140 funds tracked by Wall St. Rank hold ALDR as of Q3 2015.

  • Schonfeld Group Holdings reported no remaining Alder Biopharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Schonfeld Group Holdings sold 5,500 Alder Biopharmaceuticals shares in Q3 2015, an estimated $291K.
  • Schonfeld Group Holdings first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Schonfeld Group Holdings's Alder Biopharmaceuticals position peaked at $291K in Q2 2015.
  • 140 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2015.

Based on Schonfeld Group Holdings's 13F filing for Q3 2015, filed 13 Nov 2015.